See more : Plasson Industries Ltd (PLSN.TA) Income Statement Analysis – Financial Results
Complete financial analysis of Universe Pharmaceuticals INC (UPC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Universe Pharmaceuticals INC, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- STAR HOUSING FINANCE LIMITED (STARHFL.BO) Income Statement Analysis – Financial Results
- Universe Group plc (UNG.L) Income Statement Analysis – Financial Results
- Jinzai Food Group Co.,Ltd. (003000.SZ) Income Statement Analysis – Financial Results
- GRG Banking Equipment Co., Ltd. (002152.SZ) Income Statement Analysis – Financial Results
- Keystone Technology Co.,Ltd. (605588.SS) Income Statement Analysis – Financial Results
Universe Pharmaceuticals INC (UPC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.universe-pharmacy.com
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 32.31M | 40.14M | 47.98M | 30.70M | 33.23M | 28.51M |
| Cost of Revenue | 21.99M | 18.25M | 22.66M | 16.61M | 19.82M | 15.11M |
| Gross Profit | 10.32M | 21.89M | 25.33M | 14.09M | 13.41M | 13.41M |
| Gross Profit Ratio | 31.93% | 54.53% | 52.78% | 45.90% | 40.35% | 47.03% |
| Research & Development | 4.86M | 7.64M | 5.47M | 583.13K | 618.44K | 789.38K |
| General & Administrative | 2.22M | 1.75M | 3.30M | 1.24M | 713.65K | 704.87K |
| Selling & Marketing | 6.78M | 19.08M | 2.97M | 1.56M | 1.58M | 1.68M |
| SG&A | 9.00M | 20.84M | 6.27M | 2.80M | 2.29M | 2.39M |
| Other Expenses | -17.53K | 430.31K | -80.43K | 365.77K | 445.77K | 5.01K |
| Operating Expenses | 13.84M | 28.91M | 11.74M | 3.74M | 3.36M | 3.65M |
| Cost & Expenses | 35.84M | 47.16M | 34.39M | 20.35M | 23.18M | 18.75M |
| Interest Income | 0.00 | 0.00 | 239.55K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 156.79K | 162.40K | 101.60K | 123.76K | 129.27K | 164.92K |
| Depreciation & Amortization | 508.79K | 533.95K | 446.88K | 410.08K | 418.43K | 452.73K |
| EBITDA | -3.22M | -7.33M | 14.20M | 10.61M | 10.17M | 10.11M |
| EBITDA Ratio | -9.95% | -15.94% | 29.15% | 34.95% | 31.59% | 35.91% |
| Operating Income | -3.53M | -7.02M | 13.59M | 10.25M | 9.75M | 9.66M |
| Operating Income Ratio | -10.92% | -17.49% | 28.32% | 33.39% | 29.35% | 33.87% |
| Total Other Income/Expenses | -322.80K | -545.35K | 88.34K | -151.29K | -99.77K | -138.28K |
| Income Before Tax | -3.85M | -7.98M | 13.68M | 10.10M | 9.65M | 9.52M |
| Income Before Tax Ratio | -11.91% | -19.89% | 28.51% | 32.90% | 29.05% | 33.38% |
| Income Tax Expense | 2.31M | 752.42K | 2.36M | 2.54M | 2.10M | 1.92M |
| Net Income | -6.16M | -8.74M | 11.32M | 7.56M | 7.55M | 7.60M |
| Net Income Ratio | -19.08% | -21.76% | 23.59% | 24.62% | 22.73% | 26.66% |
| EPS | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| EPS Diluted | -1.70 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| Weighted Avg Shares Out | 3.63M | 3.63M | 3.63M | 3.68M | 3.68M | 21.00M |
| Weighted Avg Shares Out (Dil) | 3.63M | 3.63M | 3.63M | 3.68M | 3.68M | 21.00M |
UPC Donates iftar to Naguru Mosque Muslims
Uganda People’s Congress (UPC) on Monday donated an assortment of foodstuffs, during iftar dinner to Naguru Mosque Muslims in Kampala. Hon. Jimmy Akena was accompanied by UPC Secretary General Fred Ebil, Deputy secretary General Bakabulindi Kigongo, Head of media and...
UPC calls on Ugandans to donate towards Eid Al-fitr religiously
Uganda People’s Congress (UPC) has called upon all Ugandans to donate foodstuffs and other household necessities religiously towards their fellow Muslims, as they approach end of Holy Month of Ramadan fasting period. Ms. Sharon Oyat Arach, the UPC spokesperson made...
Dokolo By-Election an Eye Opener for 2026 UPC Victory: Jimmy Akena
Uganda People’s Congress (UPC) President Jimmy Akena, has said the Dokolo District Woman Member of Parliament By-election, in which UPC’s Sarah Aguti Nyangkori won with a landslide victory, is an eye opener that UPC has re-gained its past popularity and...
UPC’s triumphs in Oyam and Dokolo by-elections underscore the party’s significant strides in reclaiming its stronghold within the Lango Sub-region
On Thursday, Sarah Aguti of the Uganda People’s Congress (UPC) party emerged winner of Dokolo District Woman Member of Parliament by-election beating National Resistance Movement and other parties with 23,044 votes. Aguti beat five candidates in this by-election; Dr. Rosemary...
UPC Intensifies Dokolo Woman MP Seat Campaigns
Uganda People’s Congress (UPC) on Wednesday said the Party has intensified Dokolo District Woman Member of Parliament (MP) By-Elections campaigns. The Dokolo Woman Member of Parliament Seat fell vacant, following the demise of the Districts Woman MP, Cecilia Ogwal who...
Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today?
Universe Pharmaceuticals (NASDAQ: UPC ) stock is falling on Tuesday after the company's shares experienced a rally during the prior day of trading. Shares of UPC closed out Friday up 43.9% without any clear news from the traditional Chinese medicine company.
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results
JI'AN, China, Jan. 30, 2024 /PRNewswire/ -- Universe Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2023. Mr. Gang Lai, Chairman...
10x Genomics Comments on Second UPC Preliminary Injunction Decision
UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect PLEASANTON, Calif. , Oct. 10, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced...
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq...
Universe Pharmaceuticals INC Announces Share Consolidation
Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary...
Source: https://incomestatements.info
Category: Stock Reports